如何确保我们能够追踪和追溯新冠疫苗在全球的使用情况？ - Suppr

Suppr

超能文献

How to ensure we can track and trace global use of COVID-19 vaccines?

作者信息

Vander Stichele Robert H, Hay Christian, Fladvad Malin, Sturkenboom Miriam C J M, Chen Robert T

机构信息

European Institute for Innovation through Health Data, Unicom Project, Belgium; University of Ghent, Gent, Belgium.

GS1Global Office and ISO TC 215, WG 6, Brussels, Belgium.

出版信息

Vaccine. 2021 Jan 8;39(2):176-179. doi: 10.1016/j.vaccine.2020.11.055. Epub 2020 Nov 24.

DOI:10.1016/j.vaccine.2020.11.055

PMID:33293161

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685056/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ee/7685056/44bb51dcb187/gr1_lrg.jpg

相似文献

How to ensure we can track and trace global use of COVID-19 vaccines?

Vaccine. 2021 Jan 8;39(2):176-179. doi: 10.1016/j.vaccine.2020.11.055. Epub 2020 Nov 24.

COVID-19 vaccines: call for global push to maintain efficacy.

Nature. 2021 Feb;590(7844):36. doi: 10.1038/d41586-021-00273-y.

Oxford COVID-vaccine paper highlights lingering unknowns about results.

Nature. 2020 Dec;588(7838):378-379. doi: 10.1038/d41586-020-03504-w.

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.

Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.

COVID-19 vaccines: time to talk about the uncertainties.

Nature. 2020 Oct;586(7830):475. doi: 10.1038/d41586-020-02944-8.

COVID-19 vaccines for all?

Lancet. 2020 Jun 13;395(10240):1822-1823. doi: 10.1016/S0140-6736(20)31354-4.

Development of vaccines for SARS-CoV-2.

F1000Res. 2020 Aug 17;9. doi: 10.12688/f1000research.25998.1. eCollection 2020.

Keeping track of the SARS-CoV-2 vaccine pipeline.

Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.

Global governance for COVID-19 vaccines.

Lancet. 2020 Jun 20;395(10241):1883. doi: 10.1016/S0140-6736(20)31405-7.

A vaccine is not too far for COVID-19.

J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.

引用本文的文献

Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains.

Vaccine. 2024 Mar 7;42(7):1506-1511. doi: 10.1016/j.vaccine.2024.01.019. Epub 2024 Feb 14.

Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries.

Vaccine X. 2023 Aug 4;15:100366. doi: 10.1016/j.jvacx.2023.100366. eCollection 2023 Dec.

Data quality of reported child immunization coverage in 194 countries between 2000 and 2019.

PLOS Glob Public Health. 2022 Feb 3;2(2):e0000140. doi: 10.1371/journal.pgph.0000140. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

How to ensure we can track and trace global use of COVID-19 vaccines?

作者信息

Vander Stichele Robert H, Hay Christian, Fladvad Malin, Sturkenboom Miriam C J M, Chen Robert T

机构信息

European Institute for Innovation through Health Data, Unicom Project, Belgium; University of Ghent, Gent, Belgium.

GS1Global Office and ISO TC 215, WG 6, Brussels, Belgium.

出版信息

Vaccine. 2021 Jan 8;39(2):176-179. doi: 10.1016/j.vaccine.2020.11.055. Epub 2020 Nov 24.

DOI:10.1016/j.vaccine.2020.11.055

PMID:33293161

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685056/

Abstract

摘要

相似文献

How to ensure we can track and trace global use of COVID-19 vaccines?

Vaccine. 2021 Jan 8;39(2):176-179. doi: 10.1016/j.vaccine.2020.11.055. Epub 2020 Nov 24.

COVID-19 vaccines: call for global push to maintain efficacy.

Nature. 2021 Feb;590(7844):36. doi: 10.1038/d41586-021-00273-y.

Oxford COVID-vaccine paper highlights lingering unknowns about results.

Nature. 2020 Dec;588(7838):378-379. doi: 10.1038/d41586-020-03504-w.

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.

Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.

COVID-19 vaccines: time to talk about the uncertainties.

Nature. 2020 Oct;586(7830):475. doi: 10.1038/d41586-020-02944-8.

COVID-19 vaccines for all?

Lancet. 2020 Jun 13;395(10240):1822-1823. doi: 10.1016/S0140-6736(20)31354-4.

Development of vaccines for SARS-CoV-2.

F1000Res. 2020 Aug 17;9. doi: 10.12688/f1000research.25998.1. eCollection 2020.

Keeping track of the SARS-CoV-2 vaccine pipeline.

Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.

Global governance for COVID-19 vaccines.

Lancet. 2020 Jun 20;395(10241):1883. doi: 10.1016/S0140-6736(20)31405-7.

A vaccine is not too far for COVID-19.

J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.

引用本文的文献

Repurposing rapid diagnostic tests to detect falsified vaccines in supply chains.

Vaccine. 2024 Mar 7;42(7):1506-1511. doi: 10.1016/j.vaccine.2024.01.019. Epub 2024 Feb 14.

Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries.

Vaccine X. 2023 Aug 4;15:100366. doi: 10.1016/j.jvacx.2023.100366. eCollection 2023 Dec.

Data quality of reported child immunization coverage in 194 countries between 2000 and 2019.

PLOS Glob Public Health. 2022 Feb 3;2(2):e0000140. doi: 10.1371/journal.pgph.0000140. eCollection 2022.